Navigation Links
Access Pharmaceuticals Reports Significant Third Party Payer Reimbursement Progress for MuGard
Date:12/9/2010

ase 1/2a trial in hematological malignancies at M.D. Anderson Cancer Center in Houston, Texas.  

The company also has other advanced drug delivery technologies including CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism.  For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our cash burn rate, clinical trial plans and timelines and clinical results for ProLindac, MuGard, Thiarabine and Cobalamin and other product candidates, our ability to achieve clinical and commercial success and our ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited to Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.Contact: Company

Contact: Investor RelationsChristine Berni

Donald C. Weinberger/Diana Bittner (media)Director of Investor Relations

Wolfe Axelrod Weinberger Assoc. LLCAccess Pharmaceuticals, Inc.

(212) 370-4500(212) 786-6208
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 /PRNewswire-iReach/ -- The Centers ... new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract ... Institute (WVMI). Effective August 1, WVMI will ... West Virginia , Pennsylvania , ... and Louisiana.  The Network will engage providers ...
(Date:7/23/2014)... , July 23, 2014 ... of the "Global Electrophysiology Ablation Catheters Market ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ... remove or destroy faulty electrical pathways from sections ... (also known as cardiac arrhythmias). Cardiac arrhythmias can ...
(Date:7/23/2014)... , July 23, 2014 Creekridge ... have added 14 new vendors so far in ... Creekridge,s newest vendors are from both the ... domestic organizations to large, well-known multi-national companies. Each ... diversified suite of financing products including: standard leasing ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Creekridge Capital Signs Several New Vendor Partners 2
... Experts from PAREXEL International Corporation (Nasdaq: PRXL ... best-practice strategic partnership models to increase operating efficiency and ... Clinical Trials conference, to be held March 30-April 1, ... how PAREXEL has transformed its business to ...
... 2011 The California Public Employees, Retirement System (CalPERS) ... renewing a contract awarded to Medco Health Solutions, Inc. ... services, the company said today.  The renewal was scheduled ... (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) The CalPERS contract has not ...
Cached Medicine Technology:PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 2PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 3PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 4CalPERS Notifies Medco of Renewal Decision 2
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that can be ... now explored in a new guide posted at the Cherry ... over 30 are introduced in the guide as well as ... of creams as an alternative to surgery is one method ... the information in the new guide. Because there are hundreds ...
(Date:7/23/2014)... young adults living near Sellafield or Dounreay since the ... cancer according to research published in the British ... the Childhood Cancer Research Group at the University of ... 1963 and 2006 among those who were under 25 ... difference was found in cancer incidence from 1991-2006 between ...
(Date:7/23/2014)... scientist from the University of Exeter has developed ... diagnosing a frequently fatal lung disease which attacks ... bone marrow transplant recipients. , The lateral-flow device ... pulmonary aspergillosis, a notoriously difficult to diagnose disease ... , Invasive aspergillosis is a leading ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July 23, ... have been exposed to some form of childhood trauma than ... finding seems to apply solely to military men, not women. ... a cause for concern, given that early childhood exposure to ... civilian population has been linked to a higher adult risk ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July ... American children and teens look in the mirror and ... reported Wednesday. "Being overweight or obese is associated ... high cholesterol and diabetes," said lead researcher Neda Sarafrazi, ... Control and Prevention,s National Center for Health Statistics. ...
Breaking Medicine News(10 mins):Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:New device detects deadly lung disease 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3
... to begin studies about a vaccine that makes a person ... the name of the vaccine is undergoing trials, and if ... 2 years time. ,The vaccine targets the pleasure ... results in obliterating the urge to smoke. The vaccine is ...
... injury by maintaining Adenosine Tri Phosphate (ATP) levels in ... an antibiotic (used to trigger organ survival in transplant ... heart tissue damage after an acute heart attack might ... issue of the Journal of Molecular and Cellular Cardiology, ...
... at Stanford’s School of Medicine and Lucile Packard Children’s ... cause for mental retardation//in Down syndrome, in a gene ... normally, affecting attention, and memory. ,The researchers ... have identified a gene that, if over-produced, could cause ...
... Service suggests that reducing the dose of radiation for patients ... It is estimated that cancers caused by X-rays kill 780 ... said that many new devices that use X-rays to push ... sufficiently tested and their efficacy and safety remains unknown. ...
... For the first time in China, doctors have successfully ... a taboo on taking organs from people whom Chinese ... the first transplant with a heart extracted from a ... ethical significance," Chen Zhonghua, director of Institute of Organ ...
... cause diabetes in children and young adults, say scientists who ... people //with type 1 diabetes in Britain's Yorkshire county. ... any insulin to control levels of sugar in the blood, ... ,The researchers led by Dr Richard McNally from Leeds ...
Cached Medicine News:Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2Health News:Stanford Researchers Identify A Gene Causing Downs Syndrome 2
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
IMMCO ANA Elisa meets the guidelines for the laboratory diagnosis and monitoring of systemic autoimmune rheumatic diseases intended for the use of clinical pathologists and laboratory physicians....
... is engineered to distribute contact pressure evenly over ... back, to maximize stability and patient comfort. ... readily conformable to patient anatomy, to provide a ... wool liner is standard on both units, as ...
Medicine Products: